Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

NCT04292535 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Insulin
Exercise

Interventions

DRUG: Placebo into the intranasal mucosa
DRUG: 20 IU NovoLog Insulin aspart into the intranasal mucosa
DRUG: 40 IU NovoLog Insulin aspart into the intranasal mucosa
DRUG: 60 IU NovoLog Insulin aspart into the intranasal mucosa
DRUG: 80 IU NovoLog Insulin aspart into the intranasal mucosa
DRUG: 100 IU NovoLog Insulin aspart into the intranasal mucosa
DRUG: 120 IU NovoLog Insulin aspart into the intranasal mucosa

Sponsor

Michigan State University